NCT06868446View on ClinicalTrials.gov

Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD)

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2026

Conditions
PTSDPost Traumatic Stress Disorder
Interventions
DEVICE

Digital Therapeutic (Version 1)

Prescription digital therapeutic designed to overcome existing barriers and deliver evidence-based treatment for PTSD

DEVICE

Digital Therapeutic (Version 2)

Prescription digital therapeutic (increased dose) designed to overcome existing barriers and deliver evidence-based treatment for PTSD

BEHAVIORAL

Treatment as Usual (TAU)

Treatment as usual may include psychotherapy and/or pharmacological interventions.

Sponsors
All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Florida State University

OTHER

lead

Oui Therapeutics, Inc.

INDUSTRY

NCT06868446 - Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD) | Biotech Hunter | Biotech Hunter